SYNERGENES Trademark

Trademark Overview


On Friday, May 18, 2001, a trademark application was filed for SYNERGENES with the United States Patent and Trademark Office. The USPTO has given the SYNERGENES trademark a serial number of 76259610. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Friday, July 18, 2003. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The SYNERGENES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of human and non-human animal respiratory, immune, endocrine, cardiovascular, neoplastic and central nervous ailments, bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergies and inflammation, respiratory, airway and pulmonary vasoconstriction, impeded respiration, acute respiratory distress syndrome, renal damage and failure, ischemia, supra ventricular tachycardia, adenosine stress tests, infantile respiratory distress syndrome, pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease, leukemias, lymphomas, carcinomas, colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, metastatic cancers and cancers which metastasized to the lungs, breast, liver and prostate and central nervous system
synergenes

General Information


Serial Number76259610
Word MarkSYNERGENES
Filing DateFriday, May 18, 2001
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateFriday, July 18, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 24, 2002

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of human and non-human animal respiratory, immune, endocrine, cardiovascular, neoplastic and central nervous ailments, bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergies and inflammation, respiratory, airway and pulmonary vasoconstriction, impeded respiration, acute respiratory distress syndrome, renal damage and failure, ischemia, supra ventricular tachycardia, adenosine stress tests, infantile respiratory distress syndrome, pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease, leukemias, lymphomas, carcinomas, colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, metastatic cancers and cancers which metastasized to the lungs, breast, liver and prostate and central nervous system

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, September 16, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Monday, June 7, 2004PAPER RECEIVED
Friday, July 18, 2003ABANDONMENT - AFTER INTER PARTES DECISION
Friday, July 18, 2003OPPOSITION TERMINATED NO. 999999
Friday, July 18, 2003OPPOSITION SUSTAINED NO. 999999
Wednesday, January 22, 2003OPPOSITION INSTITUTED NO. 999999
Tuesday, September 24, 2002PUBLISHED FOR OPPOSITION
Wednesday, September 4, 2002NOTICE OF PUBLICATION
Wednesday, June 12, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2002EXAMINERS AMENDMENT MAILED
Friday, May 10, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 21, 2002REINSTATED
Monday, April 22, 2002ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, April 22, 2002ASSIGNED TO EXAMINER
Tuesday, June 26, 2001NON-FINAL ACTION MAILED
Friday, June 8, 2001ASSIGNED TO EXAMINER